Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$12.10 +0.05 (+0.41%)
As of 08/27/2025 10:07 AM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$12.00
C$12.10
50-Day Range
C$11.15
C$12.10
52-Week Range
C$9.20
C$12.40
Volume
5,950 shs
Average Volume
4,137 shs
Market Capitalization
C$138.39 million
P/E Ratio
19.64
Dividend Yield
1.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RX Stock News Headlines

FY2025 Earnings Forecast for BioSyent Issued By Bloom Burton
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
BioSyent Declares Third Quarter 2025 Dividend
BioSyent Releases Financial Results for Q2 and H1 2025
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of the year. Since then, RX stock has increased by 10.0% and is now trading at C$12.10.

BioSyent Inc. (CVE:RX) announced its quarterly earnings results on Thursday, May, 25th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $3.82 million for the quarter, compared to analysts' expectations of $4.80 million. BioSyent had a trailing twelve-month return on equity of 20.01% and a net margin of 20.60%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
8/27/2025
Record date for 9/15 Dividend
8/29/2025
Dividend Payable
9/15/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.62
Trailing P/E Ratio
19.64
Forward P/E Ratio
17.42
P/E Growth
N/A
Net Income
C$7.02 million
Net Margins
20.60%
Pretax Margin
N/A
Return on Equity
20.01%
Return on Assets
12.86%

Debt

Debt-to-Equity Ratio
2.90
Current Ratio
3.92
Quick Ratio
6.91

Sales & Book Value

Annual Sales
C$34.06 million
Price / Sales
4.06
Cash Flow
C$3.94 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.75

Miscellaneous

Outstanding Shares
11,437,447
Free Float
N/A
Market Cap
C$138.39 million
Optionable
Not Optionable
Beta
0.93
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (CVE:RX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners